No Data
No Data
Huakang Co., Ltd. (605077.SH) plans to distribute 0.7 yuan per share to 0.3 shares in 2023, excluding interest on May 28
Huakang Co., Ltd. (605077.SH) announced that the company plans to distribute a cash dividend of 0.7 yuan per share in 2023 (...
Huakang Co., Ltd. (605077.SH): Establishing a core technology research and development system for Huakang synthetic biology
Gelonghui, May 20 | Huakang Co., Ltd. (605077.SH) said on the investor interactive platform that the Synthetic Biology Joint Innovation Research and Development Center, which was jointly built with Academician Zheng Yuguo's team of Zhejiang University of Technology in 2023, relies on academician research teams to focus on synthetic biology research. At the unveiling ceremony of Huakang Co., Ltd. and the Synthetic Biology Joint Innovation Research and Development Center of Zhejiang University of Technology, Academician Zheng Yuguo pointed out that the rise and progress of synthetic biology research will bring new opportunities for the development of nutritional and health industries such as Huakang's functional sugar alcohol. Zhejiang University of Technology and Huakang jointly build an innovative research and development center for synthetic biology through industrialization projects
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) 7.7% Gain Last Week Benefited Both Retail Investors Who Own 43% as Well as Insiders
Key Insights The considerable ownership by retail investors in Zhejiang Huakang Pharmaceutical indicates that they collectively have a greater say in management and business strategy The top 12 shar
Huakang Co., Ltd. (605077.SH) announced first-quarter results. Net profit of 79.986 million yuan decreased 11.15% year over year
Huakang Co., Ltd. (605077.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 6...
Insufficient Growth At Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Hampers Share Price
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) price-to-earnings (or "P/E") ratio of 13.7x might make it look like a strong buy right now compared to the market in China, where around half
Huakang Co., Ltd. (605077.SH): Net profit in 2023 increased 16.34% year-on-year, and plans to transfer 10 to 3 to 7 yuan
Gelonghui, April 18 | Huakang Co., Ltd. (605077.SH) announced its 2023 annual report. Operating revenue for the reporting period was 2,783 billion yuan, up 26.48% year on year; net profit attributable to shareholders of listed companies was 371 million yuan, up 16.34% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 357 million yuan, up 12.26% year on year; basic earnings per share were 1.63 yuan. The company plans to distribute a cash dividend of 7 yuan (tax included) to all shareholders for every 10 shares, and plans to transfer 3 shares to all shareholders for every 10 shares in a capital reserve fund.
No Data